Ajanta Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	52,016	46,481	42,087	37,426	33,410	28,897
Revenue Growth (YoY)	14.78%	10.44%	12.45%	12.02%	15.62%	11.66%
Cost of Revenue	12,345	11,429	11,210	11,102	8,840	6,832
Gross Profit	39,671	35,052	30,877	26,324	24,570	22,065
Selling, General & Admin	12,453	11,048	9,122	7,978	6,571	5,523
Other Operating Expenses	13,027	11,279	9,944	10,241	8,667	6,478
Operating Expenses	27,156	23,768	20,420	19,527	16,491	13,162
Operating Income	12,516	11,285	10,457	6,798	8,079	8,903
Interest Expense	-198.2	-207.3	-72.1	-58.4	-102	-82.7
Interest & Investment Income	471.6	471.6	277.1	84.6	146.5	35.1
Currency Exchange Gain (Loss)	73.4	282.1	158.7	660.7	563.7	45.1
Other Non Operating Income (Expenses)	118	41.4	264.1	61.5	323.8	40.9
EBT Excluding Unusual Items	12,980	11,872	11,084	7,546	9,011	8,941
Gain (Loss) on Sale of Investments	25.2	25.2	20.1	-40	122.8	82.7
Gain (Loss) on Sale of Assets	-6	-6	34.9	-53.5	-38.7	-22.1
Pretax Income	13,000	11,892	11,139	7,453	9,095	9,002
Income Tax Expense	2,854	2,688	2,978	1,573	1,968	2,463
Net Income	10,146	9,204	8,162	5,880	7,127	6,539
Net Income to Common	10,146	9,204	8,162	5,880	7,127	6,539
Net Income Growth	13.00%	12.77%	38.81%	-17.50%	8.99%	39.80%
Shares Outstanding (Basic)	125	125	126	128	130	131
Shares Outstanding (Diluted)	125	125	126	128	130	131
Shares Change (YoY)	-0.41%	-0.66%	-1.65%	-1.19%	-0.74%	-0.21%
EPS (Basic)	81.22	73.56	64.82	45.89	54.97	50.06
EPS (Diluted)	81.21	73.53	64.77	45.89	54.96	50.06
EPS Growth	13.47%	13.53%	41.14%	-16.50%	9.79%	40.09%
Free Cash Flow	-	8,393	6,327	6,176	4,129	4,047
Free Cash Flow Per Share	-	67.05	50.21	48.20	31.84	30.98
Dividend Per Share	28.000	28.000	36.000	7.000	6.333	6.333
Dividend Growth	-	-22.22%	414.29%	10.53%	-	-26.92%
Gross Margin	76.27%	75.41%	73.36%	70.34%	73.54%	76.36%
Operating Margin	24.06%	24.28%	24.84%	18.16%	24.18%	30.81%
Profit Margin	19.50%	19.80%	19.39%	15.71%	21.33%	22.63%
Free Cash Flow Margin	-	18.06%	15.03%	16.50%	12.36%	14.01%
EBITDA	13,796	12,522	11,638	7,952	9,173	9,889
EBITDA Margin	26.52%	26.94%	27.65%	21.25%	27.46%	34.22%
D&A For EBITDA	1,280	1,238	1,181	1,154	1,094	985.9
EBIT	12,516	11,285	10,457	6,798	8,079	8,903
EBIT Margin	24.06%	24.28%	24.84%	18.16%	24.18%	30.81%
Effective Tax Rate	21.95%	22.60%	26.73%	21.10%	21.64%	27.36%
Revenue as Reported	53,304	47,426	42,933	38,413	34,567	29,157
Advertising Expenses	-	57.6	44.9	50.2	47.8	16.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.